Clinical Studies of Safety and Effectiveness of Orphan Products
Action
Published Date
Agency
CFDA
93.103
Contact Information
Marc Pitts, 301-827-7162; Marc.Pitts@FDA.HHS.GOV
Deadline
Department
Eligiblity
State and local governments, and public and private for-profit and nonprofit organizations.
Guide Page Reference
None
More Information
http://www.grants.gov/search/search.do?oppId=11589&mode=VIEW
Programe Purpose
To support the clinical development of orphan drug products for use in rare diseases or conditions where no current therapy exists or where the product will improve the existing therapy.
